𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PND27 ESTIMATING MARGINAL COST-EFFECTIVENESS USING A PERSON-LEVEL NET BENEFITS APPROACH WITH AN APPLICATION TO DISEASE-MODIFYING DRUGS IN MULTIPLE SCLEROSIS

✍ Scribed by MG Brown; C Skedgel; VA Hicks; IS Sketris; JD Fisk


Book ID
119596226
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
89 KB
Volume
10
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.